longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

JAFRON

300529

15.030.87% ( +0.13 )
Delay Closed: Sep 17, 15:00:00
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 22.86, below the reasonable range, cheaper than 97.57% of the time in the past 3 years, and the industry ranks 10/65, the industry Median 26.99.

22.86xP/E
¥15.03Stock price
¥0.66Earnings per share
22.86xP/E
Stock price¥15.03Earnings per share¥0.66

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
29.95x
Typical range
25.53x–40.82x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 26.99x
012243648

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 26.99x
0x30x60x90x120x150x
P/E ratio
Name/Symbol
300760SZMindray
24.16x1.70%¥190.01B
002223SZYUYUE MEDICAL
23.33x0.70%¥26.17B
300003SZLepu Medical
26.99x16.83%¥20.79B
002901SZDouble Medical
22.60x13.61%¥16.02B
603014SHWeigao Blood Purification
26.16x2.19%¥12.87B
300529SZJAFRON
22.86x18.12%¥12.00B
600587SHSHINVA
17.25x--¥7.35B
300206SZEdan
18.52x--¥6.54B
301367SZBMC
24.89x27.60%¥5.50B
688236SHChunli Medical
18.72x0.00%¥5.21B
688581SHAGS
20.80x79.57%¥4.45B
300326SZKinetic Medical
19.57x--¥4.40B
688410SHSWS Medical
22.73x45.87%¥4.21B
688580SHVISHEE
24.02x20.83%¥4.06B
301033SZMedprin
28.95x--¥3.54B
688358SHCHISON MEDICAL
26.37x17.31%¥3.05B
688314SHKontour Medical
29.09x--¥2.48B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.